ClinicalTrials.Veeva

Menu

Screening for Atherotic Plaques by Ultrasound for Assessing Cardiovascular Risk

C

Cabinet de Medecine Interne Générale Demetrio Pitarch

Status

Completed

Conditions

Atherosclerosis of Artery

Treatments

Diagnostic Test: ultrasound guided detection of atherosclerotic plaques

Study type

Observational

Funder types

Other

Identifiers

NCT03499496
DPitarch

Details and patient eligibility

About

Cardiovascular disease is a common diagnosed and treated condition in private practices of primary health care. There is growing evidence that atherosclerotic plaques as predictors for stroke and heart attack are more prevalent than expected based on the clinical score in people with low risk for stroke and heart attack .

Diagnosing atherosclerotic plaques can help to decide if a lipid lowering therapy should be prescribed even if the clinical risk score is low or on the other hand if they can be observed even in high lipid levels.

Full description

Both common and proximal internal carotid arteries and both common femoral arteries (including bifurcations) were screened by ultrasound in patients who came for a check-up to a primary care practice with no known cardiovascular disease and low risk for stroke and heart attack according to the AGLA/GSLA risk score which is mostly used in Switzerland.

All patients agreed and gave written informed consent to be included in this study. Presence of plaques was defined as a focal carotid intima-media thickness >0.5 cm on ultrasound. Screening was performed by a medical doctor (DP) certified for the procedure using the following ultrasound system: Toshiba Nemio XG, probe 7.5 MhZ.

Enrollment

22 patients

Sex

All

Ages

41 to 72 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • low cardiovascular risk assessed by the AGLA/GSLA-score

Exclusion criteria

  • cardiovascular disease

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems